These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 23594291)
1. Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases. Guerra-Araiza C; Álvarez-Mejía AL; Sánchez-Torres S; Farfan-García E; Mondragón-Lozano R; Pinto-Almazán R; Salgado-Ceballos H Free Radic Res; 2013 Jul; 47(6-7):451-62. PubMed ID: 23594291 [TBL] [Abstract][Full Text] [Related]
2. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Halliwell B Drugs Aging; 2001; 18(9):685-716. PubMed ID: 11599635 [TBL] [Abstract][Full Text] [Related]
3. The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases. Danta CC; Piplani P Expert Opin Drug Discov; 2014 Oct; 9(10):1205-22. PubMed ID: 25056182 [TBL] [Abstract][Full Text] [Related]
4. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879 [TBL] [Abstract][Full Text] [Related]
5. [New antioxidants as neuroprotective agents for the treatment of ischemic brain injury and neurodegenerative diseases]. Belousova MA; Korsakova EA; Gorodetskaia EA; Kalenikova EI; Medvedev OS Eksp Klin Farmakol; 2014; 77(11):36-44. PubMed ID: 25668946 [TBL] [Abstract][Full Text] [Related]
6. Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: A review. Abrahams S; Haylett WL; Johnson G; Carr JA; Bardien S Neuroscience; 2019 May; 406():1-21. PubMed ID: 30825584 [TBL] [Abstract][Full Text] [Related]
7. Vitamin E and other endogenous antioxidants in the central nervous system. Vatassery GT Geriatrics; 1998 Sep; 53 Suppl 1():S25-7. PubMed ID: 9745632 [TBL] [Abstract][Full Text] [Related]
8. [Phenolic chain-breaking antioxidants--their activity and mechanisms of action]. Kowalewska E; Litwinienko G Postepy Biochem; 2010; 56(3):274-83. PubMed ID: 21117315 [TBL] [Abstract][Full Text] [Related]
9. An overview of the pathophysiology of neurodegenerative disorders. Willner C Altern Ther Health Med; 2004; 10(4):26-34; quiz 35, 96. PubMed ID: 15285272 [No Abstract] [Full Text] [Related]
11. Methods for the detection of antioxidants which prevent age related diseases: a critical review with particular emphasis on human intervention studies. Hoelzl C; Bichler J; Ferk F; Simic T; Nersesyan A; Elbling L; Ehrlich V; Chakraborty A; Knasmüller S J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():49-64. PubMed ID: 16077190 [TBL] [Abstract][Full Text] [Related]
12. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? de Vries HE; Witte M; Hondius D; Rozemuller AJ; Drukarch B; Hoozemans J; van Horssen J Free Radic Biol Med; 2008 Nov; 45(10):1375-83. PubMed ID: 18824091 [TBL] [Abstract][Full Text] [Related]
13. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease. Polidori MC; Griffiths HR; Mariani E; Mecocci P Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806 [TBL] [Abstract][Full Text] [Related]